Clinical trial
Bone Marrow Transplant Studies for Safe and Effective Treatment of Leukemia
NCT00001623 · National Heart, Lung, and Blood Institute (NHLBI), NIH · Completed
Key facts
| NCT number | NCT00001623 |
|---|---|
| Title | Bone Marrow Transplant Studies for Safe and Effective Treatment of Leukemia |
| Official title | HLA-Matched Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation Followed by T Cell Add-Back for Hematological Malignancies |
| Lead sponsor | National Heart, Lung, and Blood Institute (NHLBI), NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | Graft vs Host Disease, Hematologic Neoplasm, Leukemia, Multiple Myeloma, Myelodysplastic Syndrome |
| Intervention type | Procedure |
| Interventions | Allogeneic Bone Marrow Transplant |
| Enrollment | 41 |
| Start date | Mar 27, 1997 |
| Primary completion | Jan 31, 2008 |
| Completion | Aug 3, 2017 |
| First posted | Nov 4, 1999 |
| Last update posted | Dec 12, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: